Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: A randomized clinical trial

Article English OPEN
Martinez, Esteban; Gonzalez-Cordon, Ana; Ferrer, Elena; Domingo, Pere; Negredo, Eugenia; Gutierrez, Felix; Portilla, Joaquin; Curran, Adrià; Podzamczer, Daniel; Ribera, Esteban; Murillas, Javier; Bernardino, Jose I.; Santos, Ignacio; Carton, Jose A.; Peraire, Joaquim; Pich, Judit; Deulofeu, Ramon; Perez, Ignacio; Gatell, Jose M.; Arnaiz, Juan A.; Beleta, Helena; Garcia, David; Pejenaute, Andrea; Ramos, Nuria; Arcaina, P.; Giner, L.; Moya, S.; Pampliega, M.; Portilla, J.; Barrera, G.; ... view all 80 authors
(2015)
  • Publisher: Oxford University Press
  • Identifiers: doi: 10.1093/cid/ciu898
  • Subject: Antiretroviral therapy | Medicina
    mesheuropmc: immune system diseases | virus diseases

This article has been accepted for publication in Clinical Infectious Diseases ©2014 The Authors .Published by Oxford University Press on Clinical Infectious Disease 60.5. DOI: 10.1093/cid/ciu898 Background. It is unclear whether metabolic or body composition effect... View more
Share - Bookmark